GIFLF:OTCMKTS
Grifols SA Class A
11,13 $
0,00%
(0,00) 1 d.
15. sept., 15:11:14 GMT-4 · USD
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: GIFLF…
Tirgus kapitalizācija
6,59 mljrd.
Vid. apjoms
543,00
Apjoms
0,00
Augstākā 52 ned.
12,90 $
Zemākā 52 ned.
10,13 $
Beta
0,90
Apgrozībā esošās akcijas
426,13 milj.
Darbinieku skaits
25 tūkst.
Tirgus kapitalizācija
6,59 mljrd.
Vid. apjoms
543,00
Apjoms
0,00
Augstākā 52 ned.
12,90 $
Zemākā 52 ned.
10,13 $
Beta
0,90
Apgrozībā esošās akcijas
426,13 milj.
Darbinieku skaits
25 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
AD HOC NEWS
·
pirms 1 dienas
Grifols stock ends the week at EUR 9.88 within a EUR 9.73-9.97 range
AD HOC NEWS
·
pirms 2 dienām
Grifols signed a 40 GWh PPA and Grifols stock gained 1.22 percent
Profils
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30.
Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
Par “Grifols SA Class A”
ĢenerāldirektorsNacho Abia
Darbinieki25 tūkst.
Dibināšanas datums1940. gada 18. nov.
Galvenais birojs-
Sektors-
Tīmekļa vietnegrifols.com